Participated · Seed · Apr 2026

Acurion develops the OncoGaze™ platform, an AI-powered image analysis system that detects clinically actionable cancer biomarkers from routine pathology slides. The technology is positioned to extract biomarker insights without requiring additional tissue or specialized molecular testing. Acurion builds on foundational research from co-founder and CSO Ludmil Alexandrov, Ph.D., and has published in leading oncology and scientific journals while expanding clinical collaborations. The company says it is moving from validation toward deployment and is focusing on clinical and regulatory milestones. Acurion closed an oversubscribed $4.3 million seed round to fund clinical validation, platform development, regulatory preparation, and commercialization. The company expects to announce further clinical collaborations and regulatory progress in the coming months.

Participated · Equity · Apr 2019

Perceivant publishes interactive, data-driven courseware that replaces traditional textbooks with cost-effective learning experiences for web and mobile applications. Each course is accompanied by analytics and real-time data to boost student engagement and provide educators with tools to analyze course efficacy. Courses leverage proprietary learning processes such as "guided learning" to reinforce objectives in low-stress environments and improve competency. The platform includes accessibility and learning tools that allow educators to tailor learning styles and increase student success. The company plans to expand its digital courseware to more colleges nationwide, targeting more than 100 new partners in the next two years, create more than 10 new courses, grow staff threefold, and expand into training schools for trade certifications. Perceivant secured more than $590k in the most recent funding, bringing total funding to $3.75M. The company was founded by Brian Rowe in 2012 and is based in Indianapolis, IN.

Participated · Equity · May 2017

Scientist.com operates the world's largest marketplace for outsourced research and scientific services, connecting buyers and sellers of pharmaceutical research services and showcasing innovative tools and technologies. The platform streamlines the source-to-settle process and hosts thousands of commercial suppliers (CROs). Scientist.com currently operates private marketplaces for 12 of the top 25 large pharmaceutical companies and the US National Institutes of Health. The company enables both large and early-stage biopharmaceutical firms to outsource most laboratory tests and studies via a private marketplace at app.scientist.com. It raised $24M in equity financing to expand its marketplace, grow its team of industry experts, and bring additional simplification and innovation to drug research. The announcement originated from San Diego and the company formerly operated as Assay Depot. Assay Depot operates an online marketplace that lets scientists source and purchase research services across more than 500 research areas. The company runs public and private marketplaces; private marketplaces serve as end-to-end vendor relationship management (VRM) systems that link scientists inside large pharmaceutical companies with 9,000 global research suppliers. Its platform is used by scientists in over 100 countries and provides ratings and reviews to capture scientist feedback. Assay Depot positions itself as the world's largest marketplace for scientific services and enables ordering services on demand, allowing research projects to be carried out without direct access to a laboratory. The company raised $3 million in Series B financing led by Bootstrap Venture Fund and will use the funds to drive continued growth of its research sourcing platform. Assay Depot operates a cloud-based pharmaceutical research platform and online marketplace that lets scientists custom-create and purchase research services and communicate with experts. The platform includes a public marketplace launched in 2008 that hosts services needed to run a drug program from initial concept to human clinical trials. It also offers private marketplaces called Contract Research Exchanges (CRXs) for companies to manage their worldwide network of internal and external research providers, and a vendor back office where vendors respond to requests and manage orders. The company raised $1.7M from private investors to expand the platform. Assay Depot is led by President and CEO Kevin Lustig and is based in San Diego, California. The company also maintains offices in Northern California and Pennsylvania.